Search

Search results

1219 results found

Current Clinical Research Studies in the Patti Lab -

Page

For more information about current studies please email Hypoglycemiastudy@joslin.harvard.edu or call (617) 309-1940 Please let us know where you live, and if we may contact you regarding future in-person or potential remote studies. Studies of New Treatment Approaches for Hypoglycemia Lucidity Study...

Healthy Human Serum Anti Carbohydrate Antibodies

Page

Paper The description for how this data was collected can be found in the manuscript titled: Unique repertoire of anti-carbohydrate antibodies in individual human serum Data The following data files can be downloaded GLAD Sessions for 105 serum samples screened against the NCFG microarray for IgG...

Probe-Seq enables transcriptional profiling of specific cell types from heterogeneous tissue by RNA-based isolation

Publication: Journal Article

Amamoto, Ryoji, Mauricio Garcia, Emma West, Jiho Choi, Sylvain Lapan, Elizabeth Lane, Norbert Perrimon, and Constance Cepko. 2019. “Probe-Seq Enables Transcriptional Profiling of Specific Cell Types from Heterogeneous Tissue by RNA-Based Isolation”. Elife 8.

One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients with Central-Involved Diabetic Macular Edema and Reduced Vision: An Open-Label Phase 1B Study

Publication: Journal Article

Sun, Jennifer, Raj Maturi, David Boyer, John Wells, Victor Gonzalez, Robert Tansley, Helen Hernandez, Andreas Maetzel, Edward Feener, and Lloyd Paul Aiello. 2019. “One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients With Central-Involved Diabetic Macular Edema and Reduced Vision: An Open-Label Phase 1B Study”. Ophthalmol Retina 3 (12): 1107-9.

Glassman, Adam, Wesley Beaulieu, Cynthia Stockdale, Roy Beck, Neil Bressler, Leanne Labriola, Michele Melia, Kristina Oliver, and Jennifer Sun. 2020. “Effect of Telephone Calls from a Centralized Coordinating Center on Participant Retention in a Randomized Clinical Trial”. Clin Trials, 1740774519894229.

Surface modification of corneal prosthesis with nano-hydroxyapatite to enhance in vivo biointegration

Publication: Journal Article

Riau, Andri, Nyein Lwin, Larisa Gelfand, Huanlong Hu, Bo Liedberg, James Chodosh, Subbu Venkatraman, and Jodhbir Mehta. 2020. “Surface Modification of Corneal Prosthesis With Nano-Hydroxyapatite to Enhance in Vivo Biointegration”. Acta Biomater 107: 299-312.

Severe reverse amblyopia with atropine penalization

Publication: Journal Article

Elhusseiny, Abdelrahman, Carolyn Wu, Sarah MacKinnon, and David Hunter. 2020. “Severe Reverse Amblyopia With Atropine Penalization”. J AAPOS.

Search

Search results

Current Clinical Research Studies in the Patti Lab -

Healthy Human Serum Anti Carbohydrate Antibodies

Probe-Seq enables transcriptional profiling of specific cell types from heterogeneous tissue by RNA-based isolation

One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients with Central-Involved Diabetic Macular Edema and Reduced Vision: An Open-Label Phase 1B Study

Neuro-Ophthalmology

Normal temporal discrimination in musician's dystonia is linked to aberrant sensorimotor processing

Site of Origin of the Ophthalmic Artery Influences the Risk for Retinal Versus Cerebral Embolic Events

Effect of telephone calls from a centralized coordinating center on participant retention in a randomized clinical trial

Surface modification of corneal prosthesis with nano-hydroxyapatite to enhance in vivo biointegration

Severe reverse amblyopia with atropine penalization